Table 1.
Patient and Index Hospitalization Characteristics by Discharge Setting (n (%) or mean ± SD unless otherwise specified) – SEER-Medicare 2010–2013
| Characteristic | All | Home | Home Health | SNF |
|---|---|---|---|---|
| Total patients - N (% of the whole study sample 58770) | 58770 (100%) | 33057 (56%) | 13592 (23%) | 12121 (21%) |
| Male (vs. Female) | 29747 (50.6%) | 17770 (53.4%) | 6716 (49.4%) | 5261 (43.4%) |
| Age (years) | ||||
| Index Admission | 77.6 ± 7.1 | 76.2 ± 6.6 | 77.9 ± 7.0 | 81.0 ± 7.2 |
| Months between Diagnosis and Index Admission | 2.5 ± 3.8 | 2.6 ± 3.9 | 2.6 ± 3.7 | 2.4 ± 3.7 |
| Race | ||||
| White NH | 47668 (81.2%) | 26733 (81.0%) | 10826 (79.7%) | 10109 (83.4%) |
| Black NH | 4974 (8.5%) | 2697 (8.2%) | 1331 (9.8%) | 946 (7.8%) |
| Hispanic | 3070 (5.2%) | 1791 (5.4%) | 746 (5.5%) | 533 (4.4%) |
| Asian or Pacific Islander/American Indian/Alaska Native NH | 3002 (5.1%) | 1803 (5.5%) | 678 (5.0%) | 521 (4.3%) |
| Married or Partnered (vs. Non-married) | 29366 (50.0%) | 18547 (56.1%) | 6726 (49.5%) | 4093 (33.8%) |
| Census Tract Socioeconomic Status (SES) | ||||
| Median Income ($) | 61513.9 ± 25634.1 | 60509.0 ± 25300.2 | 62071.9 ± 26359.9 | 63635.6 ± 25566.1 |
| % of Residents below Poverty | 14.0 ± 9.3 | 14.3 ± 9.3 | 14.1 ± 9.3 | 13.2 ± 9.1 |
| % of Non-High School Grads | 14.4 ± 9.8 | 14.6 ± 9.9 | 14.6 ± 10.1 | 13.7 ± 9.5 |
| Charlson Comorbidity Index | ||||
| 0 | 19452 (33.1%) | 11848 (35.8%) | 4210 (30.1%) | 3394 (28.0%) |
| 1 | 16946 (28.8%) | 9879 (29.9%) | 3933 (28.9%) | 3134 (25.9%) |
| 2 | 9845 (16.8%) | 5288 (16.0%) | 2333 (17.2%) | 2224 (18.4%) |
| 3 or more | 12527 (21.3%) | 6042 (18.3%) | 3116 (22.9%) | 3369 (27.8%) |
| Year of Diagnosis | ||||
| 2010 | 15334 (26.1%) | 8601 (26.0%) | 3574 (26.3%) | 3159 (26.1%) |
| 2011 | 14812 (25.2%) | 8431 (25.5%) | 3358 (24.7%) | 3023 (24.9%) |
| 2012 | 14714 (25.0%) | 8270 (25.0%) | 3372 (24.8%) | 3072 (25.3%) |
| 2013 | 13910 (23.7%) | 7755 (23.5%) | 3288 (24.2%) | 2867 (23.7%) |
| Cancer Type & Stage | ||||
| Colorectal | 18472 (31.4%) | 9666 (29.2%) | 4239 (31.2%) | 4567 (37.7%) |
| Stage II | 7498 (40.6%) | 3941 (40.8%) | 1675 (39.5%) | 1882 (41.2%) |
| Stage III | 6528 (35.3%) | 3545 (36.7%) | 1474 (34.8%) | 1509 (33.0%) |
| Stage IV | 4446 (24.1%) | 2180 (22.6%) | 1090 (25.7%) | 1176 (25.8%) |
| Lung | 29792 (50.7%) | 17218 (52.1%) | 6823 (50.2%) | 5751 (47.5%) |
| Stage II | 3551 (11.9%) | 2139 (12.4%) | 834 (12.2%) | 578 (10.1%) |
| Stage III | 7634 (25.6%) | 4688 (27.2%) | 1655 (24.3%) | 1291 (22.5%) |
| Stage IV | 18607 (62.5%) | 10391 (60.4%) | 4334 (63.5%) | 3882 (67.5%) |
| Pancreas | 6897 (11.7%) | 4303 (13.0%) | 1531 (11.3%) | 1063 (8.8%) |
| Stage II | 2521 (36.6%) | 1507 (35.0%) | 613 (40.0%) | 401 (37.7%) |
| Stage III | 692 (10.0%) | 469 (10.9%) | 135 (8.8%) | 88 (8.3%) |
| Stage IV | 3684 (53.4%) | 2327 (54.1%) | 783 (51.1%) | 574 (54.0%) |
| Bladder | 3609 (6.1%) | 1870 (5.7%) | 999 (7.4%) | 740 (6.1%) |
| Stage II | 2000 (55.4%) | 1037 (55.5%) | 531 (53.2%) | 432 (58.4%) |
| Stage III | 639 (17.7%) | 335 (17.9%) | 196 (19.6%) | 108 (14.6%) |
| Stage IV | 970 (26.9%) | 498 (26.6%) | 272 (27.2%) | 200 (27.0%) |
| Health Care Utilization prior to Index Admission | ||||
| One or More SNF Stays | 5181 (8.8%) | 1279 (3.9%) | 800 (5.9%) | 3102 (25.6%) |
| Visit with Oncologist | 16936 (28.8%) | 9763 (29.5%) | 4351 (32.0%) | 2822 (23.3%) |
| Chemotherapy | 9584 (16.3%) | 5588 (16.9%) | 2529 (18.6%) | 1467 (12.1%) |
| Radiation | 6641 (11.3%) | 3652 (11.1%) | 1803 (13.3%) | 11.86 (9.8%) |
| Targeted Chemotherapy | 1131 (1.9%) | 669 (2.0%) | 281 (2.1%) | 181 (1.5%) |
| Index Hospital Characteristics | ||||
| Location | ||||
| Urban (vs. Rural) | 53137 (91.2%) | 29746 (90.1%) | 12401 (92.1%) | 10990 (90.7%) |
| Type | ||||
| Teaching (vs. Non-teaching) | 32107 (55.1%) | 17847 (54.5%) | 7767 (57.7%) | 6493 (53.6%) |
| Index Stay DRG (top 10 listed, *surgical) | ||||
| *330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 7117 (12.2%) | 3704 (11.3%) | 1768 (13.1%) | 1645 (13.6%) |
| 181 RESPIRATORY NEOPLASMS WITH CC | 3441 (5.9%) | 2117 (6.4%) | 730 (5.4%) | 594 (4.9%) |
| 180 RESPIRATORY NEOPLASMS WITH MCC | 3196 (5.5%) | 1563 (4.7%) | 840 (6.2%) | 793 (6.6%) |
| *329 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC | 2767 (4.7%) | 615 (1.9%) | 762 (5.6%) | 1390 (11.5%) |
| *331 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC | 2477 (4.2%) | 1813 (5.5%) | 428 (3.2%) | 236 (2.0%) |
| *164 MAJOR CHEST PROCEDURES WITH CC | 2276 (3.9%) | 1399 (4.3%) | 623 (4.6%) | 254 (2.1%) |
| *167 OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH CC | 1437 (2.5%) | 895 (2.7%) | 350 (2.6%) | 192 (1.6%) |
| *166 OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MCC | 1315 (2.2%) | 618 (1.9%) | 367 (2.7%) | 330 (2.7%) |
| 435 MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC | 1276 (2.2%) | 798 (2.4%) | 283 (2.1%) | 195 (1.6%) |
| 375 DIGESTIVE MALIGNANCY WITH CC | 1258 (2.1%) | 898 (2.7%) | 180 (1.3%) | 180 (1.5%) |
Data were rarely missing (<1%, except SES variables ~4%).
P-values are not shown because all comparisons were highly significant due to the large sample size.
CC – complication or comorbidity; MCC – major complication or comorbidity